Melinta Therapeutics Inc. (MLNT) Slipped -12.99% or -0.33 To Price $2.21 On Wednesday


Melinta Therapeutics Inc. (MLNT) slipped -12.99% or -0.33 to $2.21. It is near 549194 shares traded, which is 203.76% compare to the average total volume 269529. The market cap of MLNT is $26.03 million. The year to date change is -65.95%. The 52 week price range is from $2.05 to $46.0. Price of MLNT have changed 11.89% during last week. It have changed -45.02% over last month, -50.68% over last 3 months, -76.37% over last 6 months and -93.14% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for MLNT is 3.83. It is 73.30% above current price. The 200-day Moving Averages for MLNT is 10.12. It is 357.92% above current price. The 52-week High is 46.0. It is 1981.45% from the current price. The 52-week Low is 2.05. It is -7.24% from current price.

There are some statistics of MLNT. It is has market cap $26.03 million. The share outstanding is 11.78 million. The average volume is 269529. The percent of top 15 Institution holding is 73.90%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of MLNT is -86.07%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of MLNT is -35.10%.


Tags:

Share this post